Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C21H32O5 |
Molecular Weight | 364.4758 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 8 / 8 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)CC(=O)[C@@]3([H])[C@@]2([H])CC[C@]4([H])C[C@H](O)CC[C@]34C
InChI
InChIKey=SYGWGHVTLUBCEM-ZIZPXRJBSA-N
InChI=1S/C21H32O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h12-15,18,22-23,26H,3-11H2,1-2H3/t12-,13-,14+,15+,18-,19+,20+,21+/m1/s1
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Synthesis of deuterium-labeled tetrahydrocortisol and tetrahydrocortisone for study of cortisol metabolism in humans. | 1999 Dec |
|
Modulation of cortisol metabolism by the growth hormone receptor antagonist pegvisomant in patients with acromegaly. | 2001 Jul |
|
11beta-hydroxysteroid dehydrogenase activity in proteinuric patients and the effect of angiotensin-II receptor blockade. | 2002 Jul |
|
Increased cortisol metabolites and reduced activity of 11beta-hydroxysteroid dehydrogenase in patients on hemodialysis. | 2002 May |
|
Modulation of renal calcium handling by 11 beta-hydroxysteroid dehydrogenase type 2. | 2002 Oct |
|
11beta-hydroxysteroid dehydrogenase type 1 deficiency ('apparent cortisone reductase deficiency') in a 6-year-old boy. | 2003 |
|
Altered cortisol metabolism in polycystic ovary syndrome: insulin enhances 5alpha-reduction but not the elevated adrenal steroid production rates. | 2003 Dec |
|
Endogenous urinary steroids in premenopausal women with uterine leiomyomas. | 2004 Jan |
|
Production rates of cortisol in obesity. | 2004 Sep |
|
Activity of 11beta-hydroxysteroid dehydrogenase type 2 in normotensive blacks and whites. | 2005 Summer |
|
Determination of free tetrahydrocortisol and tetrahydrocortisone ratio in urine by liquid chromatography-tandem mass spectrometry. | 2006 |
|
No effect of free fatty acids on adrenocorticotropin and cortisol secretion in healthy young men. | 2006 Aug |
|
Diurnal excretion of urinary cortisol, cortisone, and cortisol metabolites in chronic fatigue syndrome. | 2006 Feb |
|
Direct determination of the ratio of tetrahydrocortisol+allo-tetrahydrocortisol to tetrahydrocortisone in urine by LC-MS-MS. | 2006 Jan 18 |
|
RP-HPLC method with fluorescence detection for determination of small quantities of triamcinolone in plasma in presence of endogenous steroids after derivatization with 9-anthroyl nitrile; pharmacokinetic studies. | 2006 Jul 24 |
|
Urinary cortisol and cortisol metabolite excretion in chronic fatigue syndrome. | 2006 Jul-Aug |
|
Variations in urine excretion of steroid hormones after an acute session and after a 4-week programme of strength training. | 2007 Jan |
|
Simultaneous determination of tetrahydrocortisol, allotetrahydrocortisol and tetrahydrocortisone in human urine by liquid chromatography-electrospray ionization tandem mass spectrometry. | 2008 Aug |
|
Evaluation of urinary steroid profile in highly trained cyclists. | 2008 Dec |
|
Daily urinary free cortisol and cortisone excretion is associated with urine volume in healthy children. | 2008 Dec 22 |
|
Modulation of 11beta-hydroxysteroid dehydrogenase (11betaHSD) activity biomarkers and pharmacokinetics of PF-00915275, a selective 11betaHSD1 inhibitor. | 2008 Feb |
|
Development of a liquid chromatography-tandem mass spectrometry method for the determination of 23 endogenous steroids in small quantities of primate urine. | 2008 Feb 1 |
|
Determination of urine steroid profile in untrained men to evaluate recovery after a strength training session. | 2008 Jul |
|
11beta-hydroxysteroid dehydrogenase 2 activity is elevated in severe obesity and negatively associated with insulin sensitivity. | 2008 Jun |
|
Impaired glucose tolerance and insulin resistance are associated with increased adipose 11beta-hydroxysteroid dehydrogenase type 1 expression and elevated hepatic 5alpha-reductase activity. | 2008 Oct |
|
Diagnosis of diseases of steroid hormone production, metabolism and action. | 2009 |
|
Cortisol metabolism in depressed patients and healthy controls. | 2009 |
|
Recent advances in the assessment of the ratios of cortisol to cortisone and of some of their metabolites in urine by LC-MS-MS. | 2009 Apr |
|
Simultaneous determination of twelve tetrahydrocorticosteroid glucuronides in human urine by liquid chromatography/electrospray ionization-linear ion trap mass spectrometry. | 2009 Dec 15 |
|
Urinary steroid profile after the completion of concentric and concentric/eccentric trials with the same total workload. | 2009 Jun |
|
Isotope ratio mass spectrometry analysis of the oxidation products of the main and minor metabolites of hydrocortisone and cortisone for antidoping controls. | 2009 Mar |
|
Application of hyphenated mass spectrometry techniques for the analysis of urinary free glucocorticoids. | 2009 Sep |
|
Steroid assays in paediatric endocrinology. | 2010 |
|
Gas chromatography/mass spectrometry (GC/MS) remains a pre-eminent discovery tool in clinical steroid investigations even in the era of fast liquid chromatography tandem mass spectrometry (LC/MS/MS). | 2010 Aug |
|
The effect of high level tennis matches on urine steroid profiles in professional tennis players. | 2010 Dec |
|
11β-Hydroxysteroid dehydrogenase type-2 and type-1 (11β-HSD2 and 11β-HSD1) and 5β-reductase activities in the pathogenia of essential hypertension. | 2010 Feb |
|
Potential corticoid metabolites: chemical synthesis of 3- and 21-monosulfates and their double-conjugates of tetrahydrocorticosteroids in the 5alpha- and 5beta-series. | 2010 Mar |
|
Intense physical exercise increases systemic 11beta-hydroxysteroid dehydrogenase type 1 activity in healthy adult subjects. | 2010 Mar |
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
LOINC |
82894-7
Created by
admin on Fri Dec 15 14:57:36 GMT 2023 , Edited by admin on Fri Dec 15 14:57:36 GMT 2023
|
||
|
LOINC |
82895-4
Created by
admin on Fri Dec 15 14:57:36 GMT 2023 , Edited by admin on Fri Dec 15 14:57:36 GMT 2023
|
||
|
LOINC |
82851-7
Created by
admin on Fri Dec 15 14:57:36 GMT 2023 , Edited by admin on Fri Dec 15 14:57:36 GMT 2023
|
||
|
LOINC |
73894-8
Created by
admin on Fri Dec 15 14:57:36 GMT 2023 , Edited by admin on Fri Dec 15 14:57:36 GMT 2023
|
||
|
LOINC |
82896-2
Created by
admin on Fri Dec 15 14:57:36 GMT 2023 , Edited by admin on Fri Dec 15 14:57:36 GMT 2023
|
||
|
LOINC |
82878-0
Created by
admin on Fri Dec 15 14:57:36 GMT 2023 , Edited by admin on Fri Dec 15 14:57:36 GMT 2023
|
||
|
LOINC |
82901-0
Created by
admin on Fri Dec 15 14:57:36 GMT 2023 , Edited by admin on Fri Dec 15 14:57:36 GMT 2023
|
||
|
LOINC |
82879-8
Created by
admin on Fri Dec 15 14:57:36 GMT 2023 , Edited by admin on Fri Dec 15 14:57:36 GMT 2023
|
||
|
LOINC |
82849-1
Created by
admin on Fri Dec 15 14:57:36 GMT 2023 , Edited by admin on Fri Dec 15 14:57:36 GMT 2023
|
||
|
LOINC |
82848-3
Created by
admin on Fri Dec 15 14:57:36 GMT 2023 , Edited by admin on Fri Dec 15 14:57:36 GMT 2023
|
||
|
LOINC |
82857-4
Created by
admin on Fri Dec 15 14:57:36 GMT 2023 , Edited by admin on Fri Dec 15 14:57:36 GMT 2023
|
||
|
LOINC |
82862-4
Created by
admin on Fri Dec 15 14:57:36 GMT 2023 , Edited by admin on Fri Dec 15 14:57:36 GMT 2023
|
||
|
LOINC |
82855-8
Created by
admin on Fri Dec 15 14:57:36 GMT 2023 , Edited by admin on Fri Dec 15 14:57:36 GMT 2023
|
||
|
LOINC |
82900-2
Created by
admin on Fri Dec 15 14:57:36 GMT 2023 , Edited by admin on Fri Dec 15 14:57:36 GMT 2023
|
||
|
LOINC |
82899-6
Created by
admin on Fri Dec 15 14:57:36 GMT 2023 , Edited by admin on Fri Dec 15 14:57:36 GMT 2023
|
||
|
LOINC |
82854-1
Created by
admin on Fri Dec 15 14:57:36 GMT 2023 , Edited by admin on Fri Dec 15 14:57:36 GMT 2023
|
||
|
LOINC |
81795-7
Created by
admin on Fri Dec 15 14:57:36 GMT 2023 , Edited by admin on Fri Dec 15 14:57:36 GMT 2023
|
||
|
LOINC |
82856-6
Created by
admin on Fri Dec 15 14:57:36 GMT 2023 , Edited by admin on Fri Dec 15 14:57:36 GMT 2023
|
||
|
LOINC |
82861-6
Created by
admin on Fri Dec 15 14:57:36 GMT 2023 , Edited by admin on Fri Dec 15 14:57:36 GMT 2023
|
||
|
LOINC |
82898-8
Created by
admin on Fri Dec 15 14:57:36 GMT 2023 , Edited by admin on Fri Dec 15 14:57:36 GMT 2023
|
||
|
LOINC |
73893-0
Created by
admin on Fri Dec 15 14:57:36 GMT 2023 , Edited by admin on Fri Dec 15 14:57:36 GMT 2023
|
||
|
LOINC |
82850-9
Created by
admin on Fri Dec 15 14:57:36 GMT 2023 , Edited by admin on Fri Dec 15 14:57:36 GMT 2023
|
||
|
LOINC |
82897-0
Created by
admin on Fri Dec 15 14:57:36 GMT 2023 , Edited by admin on Fri Dec 15 14:57:36 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID70878591
Created by
admin on Fri Dec 15 14:57:36 GMT 2023 , Edited by admin on Fri Dec 15 14:57:36 GMT 2023
|
PRIMARY | |||
|
TETRAHYDROCORTISONE
Created by
admin on Fri Dec 15 14:57:36 GMT 2023 , Edited by admin on Fri Dec 15 14:57:36 GMT 2023
|
PRIMARY | |||
|
m10625
Created by
admin on Fri Dec 15 14:57:36 GMT 2023 , Edited by admin on Fri Dec 15 14:57:36 GMT 2023
|
PRIMARY | Merck Index | ||
|
5866
Created by
admin on Fri Dec 15 14:57:36 GMT 2023 , Edited by admin on Fri Dec 15 14:57:36 GMT 2023
|
PRIMARY | |||
|
5HF9TM2D15
Created by
admin on Fri Dec 15 14:57:36 GMT 2023 , Edited by admin on Fri Dec 15 14:57:36 GMT 2023
|
PRIMARY | |||
|
200-161-9
Created by
admin on Fri Dec 15 14:57:36 GMT 2023 , Edited by admin on Fri Dec 15 14:57:36 GMT 2023
|
PRIMARY | |||
|
53-05-4
Created by
admin on Fri Dec 15 14:57:36 GMT 2023 , Edited by admin on Fri Dec 15 14:57:36 GMT 2023
|
PRIMARY | |||
|
76984
Created by
admin on Fri Dec 15 14:57:36 GMT 2023 , Edited by admin on Fri Dec 15 14:57:36 GMT 2023
|
PRIMARY |
PARENT (METABOLITE)
SUBSTANCE RECORD